Dr Adam Clarke leads channel bio with almost 15 years of industry experience in the generation, optimisation and pre-clinical development of biologics. As a protein engineer, Adam has pioneered techniques in the discovery and engineering of monoclonal antibodies against challenging targets. Prior to joining channel bio, Adam was most recently Senior Director, Biologics Lead Antibody Discovery at Teva Pharmaceuticals. During his time at Teva, Adam led a team of scientists that consistently generated therapeutic antibodies that proceeded to first-in-human trials, several of which are currently in later stage clinical trials. Adam completed postgraduate training in experimental medicine, earning a PhD from the University of Sydney (Prof Tony Weiss lab). He is the holder of 15 patent families and 12 scientific publications.